BioSpring Gesellschaft für Biotechnologie mbH

BioSpring specializes in the manufacturing and analysis of nucleic acids, serving as a reliable CDMO partner for the pharmaceutical and biotechnology sectors, as well as academic institutions. With nearly three decades of experience, we provide support across all clinical phases and stages of drug development, extending to commercial production.

At the heart of modern therapeutics lies the promise of nucleic acids – the building blocks of life. These molecules, such as DNA and RNA, play a vital role in groundbreaking therapies, including treatments for genetic disorders, cancer, and infectious diseases. BioSpring has mastered the art and science of nucleic acid manufacturing and analysis, providing the highest quality nucleic acids like antisense oligonucleotides (ASOs), small interfering RNA (siRNA), messenger RNA (mRNA), and guide RNA (gRNA).

With our state-of-the-art facilities and a team of oligonucleotide and analytical chemists, process engineers, and quality experts, we collaborate closely with our clients to provide innovative solutions. Our commitment to quality, innovation, and scalability drives the success of our clients’ therapeutic programs, no matter the complexity.